Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new CL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need.
Kieran McGowan
Kieran.McGowan@md.catapult.org.uk
Block 35, Mereside
Alderley Park
Cheshire
SK10 4ZF
England
+44 1625708394
https://md.catapult.org.uk/
Contract value: 55000-55000
Published: 29 Jun 2021, Receipt by: 30 Apr 2021
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.
